NCT04917302 Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia Status RECRUITING Phase PHASE2
NCT04916626 The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT04911010 Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder Status UNKNOWN Phase NA
NCT04892199 Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04887792 Acetazolamide for Treatment Resistant Schizophrenia Status RECRUITING Phase PHASE1/PHASE2
NCT04874974 Feasibility of a Novel Process-based Treatment for Patients With Psychosis Status COMPLETED Phase NA
NCT04871048 Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia Status RECRUITING Phase NA
NCT04870710 Feasibility Electrical Stimulation Study for Visual Hallucinations Status COMPLETED Phase NA
NCT04867681 Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia Status COMPLETED Phase NA
NCT04865835 A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. Status COMPLETED Phase PHASE1
NCT04860830 CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia Status COMPLETED Phase PHASE3
NCT04859504 Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia Status COMPLETED Phase NA
NCT04857983 Memantine Augmentation of Targeted Cognitive Training in Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT04856657 Targeting Individual Alpha Frequencies to Enhance Perceptual Timing Status COMPLETED Phase N/A
NCT04849026 Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18 Status COMPLETED Phase PHASE1
NCT04846881 Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) Status COMPLETED Phase PHASE3
NCT04846868 Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) Status COMPLETED Phase PHASE3
NCT04839926 A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects Status UNKNOWN Phase PHASE1